GSK Q2 Adj. EPS $1.35 Beats $1.27 Estimate, Sales $11.280B Beat $10.790B Estimate
GSK (NYSE:GSK) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.27 by 6.3 percent. This is a 8.87 percent increase over earnings of $1.24 per share from the same period last
GSK made more money than people expected this quarter—both in profits per share and total sales. When a company beats what experts predicted, it means the business is running well and might be stronger than people thought.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.